The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions

por Lanzi, Anastasia, Sinicrope, F. A., Benson, A. B., Galon, Jérôme
Publicado 2020

MiR-320e is a novel prognostic biomarker in colorectal cancer

por Perez-Carbonell, L, Sinicrope, F A, Alberts, S R, Oberg, A L, Balaguer, F, Castells, A, Boland, C R, Goel, A
Publicado 2015

Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status

por Rego, R L, Foster, N R, Smyrk, T C, Le, M, O'Connell, M J, Sargent, D J, Windschitl, H, Sinicrope, F A
Publicado 2010

Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCEN...

por Taieb, J., Shi, Q., Pederson, L., Alberts, S., Wolmark, N., Van Cutsem, E., de Gramont, A., Kerr, R., Grothey, A., Lonardi, S., Yoshino, T., Yothers, G., Sinicrope, F.A., Zaanan, A., André, T.
Publicado 2019

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study

por Dienstmann, R., Mason, M. J., Sinicrope, F. A., Phipps, A. I., Tejpar, S., Nesbakken, A., Danielsen, S. A., Sveen, A., Buchanan, D. D., Clendenning, M., Rosty, C., Bot, B., Alberts, S. R., Milburn Jessup, J., Lothe, R. A., Delorenzi, M., Newcomb, P. A., Sargent, D., Guinney, J.
Publicado 2017